
Stereotaxis, Inc. – AMEX:STXS
Stereotaxis stock price today
Stereotaxis stock price monthly change
Stereotaxis stock price quarterly change
Stereotaxis stock price yearly change
Stereotaxis key metrics
Market Cap | 195.72M |
Enterprise value | 128.52M |
P/E | -6.62 |
EV/Sales | 4.56 |
EV/EBITDA | -7.25 |
Price/Sales | 4.66 |
Price/Book | 4.98 |
PEG ratio | 0.10 |
EPS | -0.24 |
Revenue | 27.10M |
EBITDA | -20.68M |
Income | -20.21M |
Revenue Q/Q | 5.07% |
Revenue Y/Y | -2.00% |
Profit margin | -66.18% |
Oper. margin | -66.71% |
Gross margin | 65.62% |
EBIT margin | -66.71% |
EBITDA margin | -76.33% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeStereotaxis stock price history
Stereotaxis stock forecast
Stereotaxis financial statements
Jun 2023 | 7.85M | -4.95M | -63.07% |
---|---|---|---|
Sep 2023 | 7.79M | -5.70M | -73.18% |
Dec 2023 | 4.56M | -5.04M | -110.41% |
Mar 2024 | 6.88M | -4.50M | -65.51% |
Sep 2025 | 11.1M | -1.65M | -14.9% |
---|---|---|---|
Oct 2025 | 11.75M | -3.33M | -28.42% |
Dec 2025 | 13.85M | -3.75M | -27.12% |
Mar 2026 | 9.3M | -4.13M | -44.46% |
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 48315000 | 21.34M | 44.18% |
---|---|---|---|
Sep 2023 | 44528000 | 20.23M | 45.43% |
Dec 2023 | 41909000 | 19.98M | 47.7% |
Mar 2024 | 39452000 | 19.42M | 49.23% |
Jun 2023 | -2.93M | 20.12M | -26K |
---|---|---|---|
Sep 2023 | -967K | -10K | 25K |
Dec 2023 | -2.43M | 0 | 26K |
Mar 2024 | -2.34M | 0 | 30K |
Stereotaxis alternative data
Aug 2023 | 130 |
---|---|
Sep 2023 | 130 |
Oct 2023 | 130 |
Nov 2023 | 130 |
Dec 2023 | 130 |
Jan 2024 | 130 |
Feb 2024 | 130 |
Mar 2024 | 122 |
Apr 2024 | 122 |
May 2024 | 122 |
Jun 2024 | 122 |
Jul 2024 | 122 |
Stereotaxis other data
Period | Buy | Sel |
---|---|---|
Aug 2023 | 75020 | 0 |
Sep 2023 | 30673 | 0 |
Nov 2023 | 75826 | 0 |
Dec 2023 | 11060 | 0 |
May 2024 | 10026 | 0 |
Quarter | Transcript |
---|---|
Q1 2024 13 May 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 4 Mar 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 9 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 10 Aug 2023 | Q2 2023 Earnings Call Transcript |
Insider | Compensation |
---|---|
Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A., CFA, CPA (1987) Chief Executive Officer & Chairman | $60,030 |
Stereotaxis Makes A Strategic Acquisition Bolstering Its Future
Imminent Magic Catheter Approval Will Spike Stereotaxis Stock
Catalysts Are Coming Soon For Stereotaxis
Stereotaxis: Replacement Cycle Timeline Drives Prudent Guidance, Creates Compelling Opportunity
Stereotaxis: Driving Robotic Revolution In Endovascular Surgery; Acquisition Potential Rising
3 Catalysts For Stereotaxis That Have Investors Excited
-
What's the price of Stereotaxis stock today?
One share of Stereotaxis stock can currently be purchased for approximately $2.95.
-
When is Stereotaxis's next earnings date?
Unfortunately, Stereotaxis's (STXS) next earnings date is currently unknown.
-
Does Stereotaxis pay dividends?
No, Stereotaxis does not pay dividends.
-
How much money does Stereotaxis make?
Stereotaxis has a market capitalization of 195.72M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 4.89% to 26.77M US dollars.
-
What is Stereotaxis's stock symbol?
Stereotaxis, Inc. is traded on the AMEX under the ticker symbol "STXS".
-
What is Stereotaxis's primary industry?
Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.
-
How do i buy shares of Stereotaxis?
Shares of Stereotaxis can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Stereotaxis's key executives?
Stereotaxis's management team includes the following people:
- Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A., CFA, CPA Chief Executive Officer & Chairman(age: 38, pay: $60,030)
-
How many employees does Stereotaxis have?
As Jul 2024, Stereotaxis employs 122 workers.
-
When Stereotaxis went public?
Stereotaxis, Inc. is publicly traded company for more then 21 years since IPO on 12 Aug 2004.
-
What is Stereotaxis's official website?
The official website for Stereotaxis is stereotaxis.com.
-
Where are Stereotaxis's headquarters?
Stereotaxis is headquartered at 710 North Tucker Boulevard, Saint Louis, MO.
-
How can i contact Stereotaxis?
Stereotaxis's mailing address is 710 North Tucker Boulevard, Saint Louis, MO and company can be reached via phone at +31 46786100.
Stereotaxis company profile:

Stereotaxis, Inc.
stereotaxis.comAMEX
122
Medical - Instruments & Supplies
Healthcare
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company also provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane full-power x-ray system, including c-arm, powered table, motorized boom, and large high-definition monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. Stereotaxis, Inc. markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to develop a magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was incorporated in 1990 and is headquartered in Saint Louis, Missouri.
Saint Louis, MO 63101
CIK: 0001289340
ISIN: US85916J4094
CUSIP: 85916J409